Health Sciences Acquisitions 2 in a preliminary proxy and prospectus filed today asks shareholders to grant a merrger deadline extension from Aug. 6 until Nov. 6. A favorable vote would also give the SPAC up to three additional monthly extensions up to Feb. 6, 2023.
The SPAC raised $160 million in its August 2020 IPO with the goal of acquiring a company in North America or Europe that is developing assets in the biopharma and medical technology sectors. Read more.
